Often Forgotten Manifestations of Systemic Sclerosis

Rheumatic Disease Clinics of North America

Volumn 34, Issue 1, 2008, Pages 221-238

  Shah, Ami A ^a   Wigley, Fredrick M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BISPHOSPHONIC ACID DERIVATIVE; CEVIMELINE; CORTICOSTEROID; FLUORIDE; GLYCERYL TRINITRATE; PHOSPHODIESTERASE INHIBITOR; PILOCARPINE; URSODEOXYCHOLIC ACID; VASOACTIVE AGENT;

AVASCULAR NECROSIS; BONE ATROPHY; CLINICAL FEATURE; DYSPHAGIA; ERECTILE DYSFUNCTION; FECES INCONTINENCE; HUMAN; KIDNEY DISEASE; LIVER DISEASE; MOUTH DISEASE; NEUROLOGICAL COMPLICATION; OSTEOLYSIS; PERIODONTAL DISEASE; PHARYNX DISEASE; PHYSIOTHERAPY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SCLERODERMA; SYSTEMIC SCLEROSIS; THYROID DISEASE; WEAKNESS; WRIST DISEASE; XEROSTOMIA;

FEMALE; HUMANS; MALE; SCLERODERMA, SYSTEMIC;

EID: 40449119771     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.10.002     Document Type: Review

References (104)

1. Avouac J., Guerini H., Wipff J., et al. Radiological hand involvement in systemic sclerosis. Ann Rheum Dis 65 8 (2006) 1088-1092
2. Benitha R., Modi M., and Tikly M. Osteolysis of the cervical spine and mandible in systemic sclerosis: a case report with computed tomography and magnetic resonance imaging findings. Rheumatology (Oxford) 41 10 (2002) 1198-1200
3. Bassett L.W., Blocka K.L., Furst D.E., et al. Skeletal findings in progressive systemic sclerosis (scleroderma). AJR Am J Roentgenol 136 6 (1981) 1121-1126
4. Bertouch J.V., Gordon T.P., Henderson D., et al. Asymptomatic osteolysis of ribs and clavicles in progressive systemic sclerosis. Aust N Z J Med 12 6 (1982) 627-629
5. Olutola P.S., and Adelowo F. Osteolysis of the shaft of tubular bones in systemic scleroderma. Diagn Imaging Clin Med 54 6 (1985) 322-325
6. Wild W., and Beetham Jr. W.P. Erosive arthropathy in systemic scleroderma. JAMA 232 5 (1975) 511-512
7. Ostojic P., and Damjanov N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol 25 4 (2006) 453-457
8. Rodnan G.P., and Medsger T.A. The rheumatic manifestations of progressive systemic sclerosis (scleroderma). Clin Orthop Relat Res 57 (1968) 81-93
9. Glimcher M.J., and Kenzora J.E. The biology of osteonecrosis of the human femoral head and its clinical implications: II. The pathological changes in the femoral head as an organ and in the hip joint. Clin Orthop Relat Res 139 (1979) 283-312
10. Campbell P.M., and LeRoy E.C. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 4 4 (1975) 351-368
11. Fossaluzza V., Peressini A., and De Vita S. Multifocal ischemic necrosis of bone in scleroderma. Clin Rheumatol 10 1 (1991) 95-97
12. Martinez-Cordero E. Avascular necrosis of bone in systemic sclerosis. Clin Rheumatol 11 3 (1992) 443-444
13. Taccari E., Spadaro A., Riccieri V., et al. Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two cases. Clin Rheumatol 8 3 (1989) 386-392
14. Wilde A.H., Mankin H.J., and Rodman G.P. Avascular necrosis of the femoral head in scleroderma. Arthritis Rheum 13 4 (1970) 445-447
15. Kawai H., Tsuyuguchi Y., Yonenobu K., et al. Avascular necrosis of the carpal scaphoid associated with progressive systemic sclerosis. Hand 15 3 (1983) 270-273
16. Agus B. Bilateral aseptic necrosis of the lunate in systemic sclerosis. Clin Exp Rheumatol 5 2 (1987) 155-157
17. Matsumoto A.K., Moore R., Alli P., et al. Three cases of osteonecrosis of the lunate bone of the wrist in scleroderma. Clin Exp Rheumatol 17 6 (1999) 730-732
18. Wood R.E., and Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg Oral Med Oral Pathol 65 2 (1988) 172-178
19. Rout P.G., Hamburger J., and Potts A.J. Orofacial radiological manifestations of systemic sclerosis. Dentomaxillofac Radiol 25 4 (1996) 193-196
20. Eversole L.R., Jacobsen P.L., and Stone C.E. Oral and gingival changes in systemic sclerosis (scleroderma). J Periodontol 55 3 (1984) 175-178
21. Rasker J.J., Jayson M.I., Jones D.E., et al. Sjögren's syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol 19 1 (1990) 57-65
22. Drosos A.A., Andonopoulos A.P., Costopoulos J.S., et al. Sjögren's syndrome in progressive systemic sclerosis. J Rheumatol 15 6 (1988) 965-968
23. Avouac J., Sordet C., Depinay C., et al. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 54 7 (2006) 2243-2249
24. Hong P., Pope J.E., Ouimet J.M., et al. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. J Rheumatol 31 3 (2004) 508-513
25. Lally E.V., and Jimenez S.A. Impotence in progressively systemic sclerosis. Ann Intern Med 95 2 (1981) 150-153
26. Rossman B., and Zorgniotti A.W. Progressive systemic sclerosis (scleroderma) and impotence. Urology 33 3 (1989) 189-192
27. Nehra A., Hall S.J., Basile G., et al. Systemic sclerosis and impotence: a clinicopathological correlation. J Urol 153 4 (1995) 1140-1146
28. Nowlin N.S., Brick J.E., Weaver D.J., et al. Impotence in scleroderma. Ann Intern Med 104 6 (1986) 794-798
29. Aversa A., Proietti M., Bruzziches R., et al. The penile vasculature in systemic sclerosis: a duplex ultrasound study. J Sex Med 3 3 (2006) 554-558
30. Merla A., Romani G.L., Tangherlini A., et al. Penile cutaneous temperature in systemic sclerosis: a thermal imaging study. Int J Immunopathol Pharmacol 20 1 (2007) 139-144
31. Lotfi M.A., Varga J., and Hirsch I.H. Erectile dysfunction in systemic sclerosis. Urology 45 5 (1995) 879-881
32. Nowlin N.S., Zwillich S.H., Brick J.E., et al. Male hypogonadism and scleroderma. J Rheumatol 12 3 (1985) 605-606
33. Lally E.V., and Jimenez S.A. Erectile failure in systemic sclerosis. N Engl J Med 322 19 (1990) 1398-1399
34. Klein L.E., and Posner M.S. Progressive systemic sclerosis and impotence. Ann Intern Med 95 5 (1981) 658-659
35. Ahmad S. Scleroderma and impotence: response to nitroglycerin applied to the fingers and penis. Southampt Med J 83 12 (1990) 1495
36. Ostojic P., and Damjanov N. The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis. Clin Rheumatol 26 10 (2007) 1671-1674
37. Rubesin S.E. Oral and pharyngeal dysphagia. Gastroenterol Clin North Am 24 2 (1995) 331-352
38. Hila A., Castell J.A., and Castell D.O. Pharyngeal and upper esophageal sphincter manometry in the evaluation of dysphagia. J Clin Gastroenterol 33 5 (2001) 355-361
39. Montesi A., Pesaresi A., Cavalli M.L., et al. Oropharyngeal and esophageal function in scleroderma. Dysphagia 6 4 (1991) 219-223
40. Rajapakse C.N., Bancewicz J., Jones C.J., et al. Pharyngo-oesophageal dysphagia in systemic sclerosis. Ann Rheum Dis 40 6 (1981) 612-614
41. Cruse J.P., Edwards D.A., Smith J.F., et al. The pathology of a cricopharyngeal dysphagia. Histopathology 3 3 (1979) 223-232
42. Barrera P., den Broeder A.A., van den Hoogen F.H., et al. Postural changes, dysphagia, and systemic sclerosis. Ann Rheum Dis 57 6 (1998) 331-338
43. Stainforth J., and Goodfield M.D. Severe oropharyngeal deglutition abnormalities in a patient with systemic sclerosis, managed with a gastrostomy. Br J Dermatol 130 5 (1994) 682-683
44. Trezza M., Krogh K., Egekvist H., et al. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 34 4 (1999) 409-413
45. D'Angelo W.A., Fries J.F., Masi A.T., et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46 3 (1969) 428-440
46. Engel A.F., Kamm M.A., and Talbot I.C. Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence. Gut 35 6 (1994) 857-859
47. Malandrini A., Selvi E., Villanova M., et al. Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases. J Rheumatol 27 5 (2000) 1203-1206
48. Akesson A., and Ekman R. Gastrointestinal regulatory peptides in systemic sclerosis. Arthritis Rheum 36 5 (1993) 698-703
49. Jaffin B.W., Chang P., and Spiera H. Fecal incontinence in scleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications. J Clin Gastroenterol 25 3 (1997) 513-517
50. Chiou A.W., Lin J.K., and Wang F.M. Anorectal abnormalities in progressive systemic sclerosis. Dis Colon Rectum 32 5 (1989) 417-421
51. Heyt G.J., Oh M.K., Alemzadeh N., et al. Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence. Dig Dis Sci 49 6 (2004) 1040-1045
52. Leighton J.A., Valdovinos M.A., Pemberton J.H., et al. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 36 2 (1993) 182-185
53. Hamel-Roy J., Devroede G., Arhan P., et al. Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 88 1 Pt 1 (1985) 1-7
54. Lock G., Zeuner M., Lang B., et al. Anorectal function in systemic sclerosis: correlation with esophageal dysfunction?. Dis Colon Rectum 40 11 (1997) 1328-1335
55. Whitehead W.E., Taitelbaum G., Wigley F.M., et al. Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis. Gastroenterology 96 2 Pt 1 (1989) 428-432
56. Wald A. Clinical practice. Fecal incontinence in adults. N Engl J Med 356 16 (2007) 1648-1655
57. Kenefick N.J., Vaizey C.J., Nicholls R.J., et al. Sacral nerve stimulation for faecal incontinence due to systemic sclerosis. Gut 51 6 (2002) 881-883
58. Steen V.D. Scleroderma renal crisis. Rheum Dis Clin North Am 29 2 (2003) 315-333
59. Steen V.D. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35 1 (2005) 35-42
60. Steen V.D., Syzd A., Johnson J.P., et al. Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32 4 (2005) 649-655
61. Arnaud L., Huart A., Plaisier E., et al. ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the normotensive scleroderma renal crisis. Clin Nephrol 68 3 (2007) 165-170
62. Anders H.J., Wiebecke B., Haedecke C., et al. MPO-ANCA-positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease?. Am J Kidney Dis 33 4 (1999) E3
63. Kobayashi M., Saito M., Minoshima S., et al. A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and antiglomerular basement membrane antibody (anti-GBM Ab). Nippon Jinzo Gakkai Shi 37 3 (1995) 207-211
64. Martinez Ara J., Picazo M.L., Torre A., et al. Progressive systemic sclerosis associated with antimyeloperoxidase ANCA vasculitis with renal and cutaneous involvement. Nefrologia 20 4 (2000) 383-386
65. Katrib A., Sturgess A., and Bertouch J.V. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 19 1-2 (1999) 61-63
66. Kamen D.L., Wigley F.M., and Brown A.N. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma-a different kind of renal crisis. J Rheumatol 33 9 (2006) 1886-1888
67. Kameda H., Kuwana M., Hama N., et al. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases. J Rheumatol 24 2 (1997) 400-403
68. Hirakata M., Akizuki M., Miyachi K., et al. Coexistence of CREST syndrome and primary biliary cirrhosis. Serological studies of two cases. J Rheumatol 15 7 (1988) 1166-1170
69. Nakamura T., Higashi S., Tomoda K., et al. Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjögren's syndrome and thyroid dysfunction. Clin Rheumatol 26 4 (2007) 596-600
70. Marie I., Levesque H., Tranvouez J.L., et al. Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome?. Rheumatology (Oxford) 40 1 (2001) 102-106
71. Yabe H., Noma K., Tada N., et al. A case of CREST syndrome with rapidly progressive liver damage. Intern Med 31 1 (1992) 69-73
72. Ishikawa M., Okada J., Shibuya A., et al. CRST syndrome (calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis. Intern Med 34 1 (1995) 6-9
73. West M., Jasin H.E., and Medhekar S. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series. Semin Arthritis Rheum 35 6 (2006) 344-348
74. Goulis J., Leandro G., and Burroughs A.K. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 354 9184 (1999) 1053-1060
75. Kahl L.E., Medsger Jr. T.A., and Klein I. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J Rheumatol 13 1 (1986) 103-107
76. Gordon M.B., Klein I., Dekker A., et al. Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med 95 4 (1981) 431-435
77. Horita M., Takahashi N., Seike M., et al. A case of primary biliary cirrhosis associated with Hashimoto's thyroiditis, scleroderma and Sjögren's syndrome. Intern Med 31 3 (1992) 418-421
78. Biro E., Szekanecz Z., Czirjak L., et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25 2 (2006) 240-245
79. Kucharz E.J. Thyroid disorders in patients with progressive systemic sclerosis: a review. Clin Rheumatol 12 2 (1993) 159-161
80. De Keyser L., Narhi D.C., Furst D.E., et al. Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest 13 2 (1990) 161-169
81. Ghayad E., Tohme A., Haddad F., et al. Scleroderma with anomalies of the thyroid function. 7 cases. Ann Med Interne (Paris) 148 4 (1997) 307-310
82. Shahin A.A., Abdoh S., and Abdelrazik M. Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity. Z Rheumatol 61 6 (2002) 703-709
83. Molteni M., Barili M., Eisera N., et al. Antithyroid antibodies in Italian scleroderma patients: association of antithyroid peroxidase (anti-TPO) antibodies with HLA-DR15. Clin Exp Rheumatol 15 5 (1997) 529-534
84. Innocencio R.M., Romaldini J.H., and Ward L.S. High prevalence of thyroid autoantibodies in systemic sclerosis and rheumatoid arthritis but not in the antiphospholipid syndrome. Clin Rheumatol 22 6 (2003) 494
85. Antonelli A., Ferri C., Fallahi P., et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 156 4 (2007) 431-437
86. Herrick A.L. Neurological involvement in systemic sclerosis. Br J Rheumatol 34 11 (1995) 1007-1008
87. Teasdall R.D., Frayha R.A., and Shulman L.E. Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore) 59 2 (1980) 149-159
88. Farrell D.A., and Medsger Jr. T.A. Trigeminal neuropathy in progressive systemic sclerosis. Am J Med 73 1 (1982) 57-62
89. Lee P., Bruni J., and Sukenik S. Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol 11 4 (1984) 480-483
90. Mondelli M., Romano C., Della Porta P.D., et al. Electrophysiological evidence of "nerve entrapment syndromes" and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma). J Neurol 242 4 (1995) 185-194
91. Poncelet A.N., and Connolly M.K. Peripheral neuropathy in scleroderma. Muscle Nerve 28 3 (2003) 330-335
92. Lori S., Matucci-Cerinic M., Casale R., et al. Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. Clin Exp Rheumatol 14 6 (1996) 601-605
93. Badakov S. Ultrastructural changes of cutaneous nerves in scleroderma. Folia Med (Plovdiv) 34 3-4 (1992) 57-64
94. Dyck P.J., Hunder G.G., and Dyck P.J. A case-control and nerve biopsy study of CREST multiple mononeuropathy. Neurology 49 6 (1997) 1641-1645
95. Di Trapani G., Tulli A., La Cara A., et al. Peripheral neuropathy in course of progressive systemic sclerosis. Light and ultrastructural study. Acta Neuropathol (Berl) 72 2 (1986) 103-110
96. Casale R., Frazzitta G., Fundaro C., et al. Blink reflex discloses CNS dysfunction in neurologically asymptomatic patients with systemic sclerosis. Clin Neurophysiol 115 8 (2004) 1917-1920
97. Klimiuk P.S., Taylor L., Baker R.D., et al. Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis 47 7 (1988) 542-545
98. Cohen S., Fisher R., Lipshutz W., et al. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J Clin Invest 51 10 (1972) 2663-2668
99. Iovino P., Valentini G., Ciacci C., et al. Proximal stomach function in systemic sclerosis: relationship with autonomic nerve function. Dig Dis Sci 46 4 (2001) 723-730
100. Ferri C., Emdin M., Giuggioli D., et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24-hour heart rate variability analysis. Br J Rheumatol 36 6 (1997) 669-676
101. Raszewa M., Hausmanowa-Petrusewicz I., Blaszczyk M., et al. Sympathetic skin response in scleroderma. Electromyogr Clin Neurophysiol 31 8 (1991) 467-472
102. Terenghi G., Bunker C.B., Liu Y.F., et al. Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis. J Pathol 164 3 (1991) 245-252
103. Wallengren J., Akesson A., Scheja A., et al. Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosis. Acta Derm Venereol 76 2 (1996) 126-128
104. Clements P.J., Furst D.E., Campion D.S., et al. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum 21 1 (1978) 62-71